AI could help heart surgery patients get the right Anti-Inflammatory drug
NCT ID NCT07583290
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is looking at whether an artificial intelligence tool can help doctors decide which heart surgery patients might benefit from a drug called ulinastatin. Ulinastatin is used to reduce inflammation after surgery, but it doesn't work for everyone. Researchers will analyze data from 10,000 patients across four heart centers in China to build and test the AI tool. The goal is to personalize treatment and improve outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ulinastatin
- What this could lead to
- If successful, this could help doctors personalize anti-inflammatory treatment for heart surgery patients, potentially reducing complications.
- What could go wrong
- This is an observational study, not a controlled trial, so it cannot prove cause and effect. The AI tool needs further validation before it can be used in practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Center for Cardiac Surgery and Critical Care
Beijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Software-Guided heart procedures: a new standard for coronary care?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program
- Can balloon timing make or break heart artery success?
- AI may predict transfusion needs to shield ICU patients from organ failure
- Can we predict which heart aneurysms will grow?